Handling and reporting of radical prostatectomy specimens

Diagnostic Histopathology

Volumn 17, Issue 10, 2011, Pages 428-433

  Egevad, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Grade; Pathology; Prostate cancer; Prostatectomy; Stage

Indexed keywords

FORMALDEHYDE;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; PRACTICE GUIDELINE; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATECTOMY; RISK FACTOR; SEMINAL VESICLE; TISSUE SECTION; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 80052591184     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2011.06.007     Document Type: Article

References (41)

1. Epstein J.I., Amin M., Boccon-Gibod L., et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005, 216:34-63.
2. Epstein J.I., Allsbrook W.C., Amin M.B., Egevad L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005, 29:1228-1242.
3. Egevad L., Algaba F., Berney D.M., et al. Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 2008, 53:333-339.
4. Egevad L., Srigley J.R., Delahunt B. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens: rationale and organization. Mod Pathol 2011, 24:1-5.
5. Samaratunga H., Montironi R., True L., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2011, 24:6-15.
6. van der Kwast T.H., Amin M.B., Billis A., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2011, 24:16-25.
7. Magi-Galluzzi C., Evans A.J., Delahunt B., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2011, 24:26-38.
8. Berney D.M., Wheeler T.M., Grignon D.J., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol 2011, 24:39-47.
9. Tan P.H., Cheng L., Srigley J.R., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol 2011, 24:48-57.
10. Srigley J.R., Humphrey P.A., Amin M.B., et al. Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med 2009, 133:1568-1576.
11. AJCC cancer staging manual 2010, Springer. 7th edn.
12. Hoedemaeker R.F., Ruijter E.T.G., Ruizeveld-de Winter J.A., van der Kaa C.A., van der Kwast T.H. Processing radical prostatectomy specimens. J Urol Pathol 1998, 9:211-222.
13. Jonmarker S., Valdman A., Lindberg A., Hellstrom M., Egevad L. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 2006, 449:297-301.
14. Srigley J.R., Amin M.B., Bostwick D.G., Grignon D.J., Hammond M.E. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer committee. Arch Pathol Lab Med 2000, 124:1034-1039.
15. Hall G.S., Kramer C.E., Epstein J.I. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 1992, 16:315-324.
16. Sehdev A.E., Pan C.C., Epstein J.I. Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. Hum Pathol 2001, 32:494-499.
17. Furman J., Murphy W.M., Rice L., Drew P.A., Narayan P. Prostatectomy tissue for research: balancing patient care and discovery. Am J Clin Pathol 1998, 110:4-9.
18. Wheeler T.M., Lebovitz R.M. Fresh tissue harvest for research from prostatectomy specimens. Prostate 1994, 25:274-279.
19. Egevad L., Engström K., Busch C. A new method for handling radical prostatectomies enabling fresh tissue harvesting, whole mount sections and landmarks for alignment of sections. J Urol Pathol 1998, 9:17-28.
20. Ruijter E.T., Miller G.J., Aalders T.W., et al. Rapid microwave-stimulated fixation of entire prostatectomy specimens. Biomed-II MPC study group. J Pathol 1997, 183:369-375.
21. Ohori M., Scardino P.T., Lapin S.L., Seale-Hawkins C., Link J., Wheeler T.M. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993, 17:1252-1261.
22. McNeal J.E. The zonal anatomy of the prostate. Prostate 1981, 2:35-49.
23. Wheeler T.M., Dillioglugil O., Kattan M.W., et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol 1998, 29:856-862.
24. Epstein J.I., Pizov G., Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993, 71:3582-3593.
25. Sung M.T., Lin H., Koch M.O., Davidson D.D., Cheng L. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer. Am J Surg Pathol 2007, 31:311-318.
26. Vis A.N., Schroder F.H., van der Kwast T.H. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 2006, 50:258-265.
27. Watson R.B., Civantos F., Soloway M.S. Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 1996, 48:80-90.
28. Weldon V.E., Tavel F.R., Neuwirth H., Cohen R. Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. J Urol 1995, 153:1565-1569.
29. Epstein J.I., Partin A.W., Potter S.R., Walsh P.C. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000, 56:283-288.
30. Epstein J.I., Carmichael M., Partin A.W., Walsh P.C. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993, 149:1478-1481.
31. Kikuchi E., Scardino P.T., Wheeler T.M., Slawin K.M., Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 2004, 172:508-511.
32. Humphrey P.A., Walther P.J., Currin S.M., Vollmer R.T. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 1991, 15:1165-1170.
33. Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. Pathology and genetics of tumours of the urinary system and male genital organs 2004, IARC Press.
34. Albertsen P.C., Fryback D.G., Storer B.E., Kolon T.F., Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995, 274:626-631.
35. Egevad L., Granfors T., Karlberg L., Bergh A., Stattin P. Prognostic value of the Gleason score in prostate cancer. BJU Int 2002, 89:538-542.
36. Epstein J.I., Partin A.W., Sauvageot J., Walsh P.C. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996, 20:286-292.
37. Hull G.W., Rabbani F., Abbas F., Wheeler T.M., Kattan M.W., Scardino P.T. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002, 167:528-534.
38. Green G.A., Hanlon A.L., Al-Saleem T., Hanks G.E. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer 1998, 83:971-976.
39. Chan T.Y., Partin A.W., Walsh P.C., Epstein J.I. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology 2000, 56:823-827.
40. Sakr W.A., Tefilli M.V., Grignon D.J., et al. Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology 2000, 56:730-734.
41. Stamey T.A., McNeal J.E., Yemoto C.M., Sigal B.M., Johnstone I.M. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999, 281:1395-1400.